Search Page

1

Cite

Share

Jurkat T cells and development of the T-cell receptor signalling paradigm.

Abraham RT, Weiss A. Abraham RT, et al. Nat Rev Immunol. 2004 Apr;4(4):301-8. doi: 10.1038/nri1330. Nat Rev Immunol. 2004. PMID: 15057788 Review. No abstract available.

Cite

Share

2

Cite

Share

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide.

Jan M, Scarfò I, Larson RC, Walker A, Schmidts A, Guirguis AA, Gasser JA, Słabicki M, Bouffard AA, Castano AP, Kann MC, Cabral ML, Tepper A, Grinshpun DE, Sperling AS, Kyung T, Sievers QL, Birnbaum ME, Maus MV, Ebert BL. Jan M, et al. Sci Transl Med. 2021 Jan 6;13(575):eabb6295. doi: 10.1126/scitranslmed.abb6295. Sci Transl Med. 2021. PMID: 33408186 Free PMC article.

Cite

Share

3

Cite

Share

Jurkat T Cells are Immunophenotypically Distinct from T-Cell Acute Lymphoblastic Leukemia Cells Due to High-Level Surface Expression of CD5.

Singh K, Kumari S, Singh B, Choubey RB, Mitra DK, Rai AK. Singh K, et al. Cancer Invest. 2022 Sep;40(8):675-679. doi: 10.1080/07357907.2022.2095397. Epub 2022 Jul 5. Cancer Invest. 2022. PMID: 35758332

Cite

Share

4

Cite

Share

Chemical Glycoproteomics.

Palaniappan KK, Bertozzi CR. Palaniappan KK, et al. Chem Rev. 2016 Dec 14;116(23):14277-14306. doi: 10.1021/acs.chemrev.6b00023. Epub 2016 Nov 18. Chem Rev. 2016. PMID: 27960262 Free PMC article. Review.

Cite

Share

5

Cite

Share

Reduction of Ca²⁺ Entry by a Specific Block of KCa3.1 Channels Optimizes Cytotoxic Activity of NK Cells against T-ALL Jurkat Cells.

Olivas-Aguirre M, Cruz-Aguilar LH, Pottosin I, Dobrovinskaya O. Olivas-Aguirre M, et al. Cells. 2023 Aug 15;12(16):2065. doi: 10.3390/cells12162065. Cells. 2023. PMID: 37626875 Free PMC article.

Cite

Share

6

Cite

Share

Nanosecond-pulsed DBD plasma treatment on human leukaemia Jurkat cells and monoblastic U937 cells in vitro.

Erfani R, Carmichael C, Sofokleous T, Wang Q. Erfani R, et al. Sci Rep. 2022 Apr 15;12(1):6270. doi: 10.1038/s41598-022-10056-8. Sci Rep. 2022. PMID: 35428374 Free PMC article.

Cite

Share

7

Cite

Share

Ionizing Radiation Induces Morphological Changes and Immunological Modulation of Jurkat Cells.

Voos P, Fuck S, Weipert F, Babel L, Tandl D, Meckel T, Hehlgans S, Fournier C, Moroni A, Rödel F, Thiel G. Voos P, et al. Front Immunol. 2018 Apr 30;9:922. doi: 10.3389/fimmu.2018.00922. eCollection 2018. Front Immunol. 2018. PMID: 29760710 Free PMC article.

Cite

Share

8

Cite

Share

The Role of Redox Status Changes in Dexamethasone-Induced Apoptosis in Jurkat Tumor Cells.

Nosareva ОL, Stepovaya EA, Shakhristova EV, Karpov RM. Nosareva ОL, et al. Bull Exp Biol Med. 2022 Feb;172(4):464-466. doi: 10.1007/s10517-022-05414-5. Epub 2022 Feb 17. Bull Exp Biol Med. 2022. PMID: 35175483

Cite

Share

9

Cite

Share

Fugetaxis of Cell-in-Catalytic-Coat Nanobiohybrids in Glucose Gradients.

Rheem HB, Choi H, Yang S, Han S, Rhee SY, Jeong H, Lee KB, Lee Y, Kim IS, Lee H, Choi IS. Rheem HB, et al. Small. 2023 Oct;19(41):e2301431. doi: 10.1002/smll.202301431. Epub 2023 Jun 6. Small. 2023. PMID: 37282761

Cite

Share

10

Cite

Share

Low-dose doxorubicin-induced necrosis in Jurkat cells and its acceleration and conversion to apoptosis by antioxidants.

Sugimoto K, Tamayose K, Sasaki M, Hayashi K, Oshimi K. Sugimoto K, et al. Br J Haematol. 2002 Jul;118(1):229-38. doi: 10.1046/j.1365-2141.2002.03577.x. Br J Haematol. 2002. PMID: 12100152 Free article.

Cite

Share